Optimind Pharma Corp. — Regulatory Filings 2020

Oct 20, 2020

==> picture [120 x 34] intentionally omitted <==

CERTIFICATE

Pursuant to Section 2.20 of National Instrument 54-101

• TO: Ontario Securities Commission, British Columbia Securities Commission and Alberta Securities Commission

• RE: Annual and Special Meeting of Shareholders of Loon Energy Corporation (the “ Corporation ”) to be held on December 8, 2020 (the “ Meeting ”)

In connection with the Meeting, the undersigned, being an officer of the Corporation, hereby certifies for and on behalf of the Corporation, and not in his personal capacity, that:

• (a) the Corporation has made arrangements to have proxy-related materials for the Meeting sent in compliance with the applicable timing requirements of National Instrument 54-101 – “Communication with Beneficial Owners of Securities of a Reporting Issuer” (the “ Instrument ”);

• (b) the Corporation has arranged to have carried out all of the requirements of the Instrument in addition to those described in paragraph (a) above; and

• (c) the Corporation is relying upon section 2.20 of the Instrument to abridge the time periods prescribed by sections 2.2(1) and 2.5(1) of the Instrument applicable to the Meeting.

DATED the 20[th] day of October, 2020.

LOON ENERGY CORPORATION

Per: "Norman W. Holton"

Norman W. Holton President and Chief Executive Officer

15346942.1